FABA panel at BioAsia to discuss challenges to innovation

February 14, 2022 07:47 pm | Updated 07:47 pm IST - HYDERABAD

BioAsia 2022 will feature a panel discussion by the Federation of Asian Biotech Associations (FABA) on “Challenges in building innovation engine in Pharma and biopharma sectors”.

Scheduled for 9.30 am. on February 25, the panel will feature CCMB director Vinay Nandicoori, well known virologist Gagandeep Kang of CMC Vellore; president and head at Biologics of Aurobindo Pharma Satakarni Makkapati, Tata Medical and Diagnostics CEO Girish Krishnamurthy and University of Hyderabad professor Ashwini Nangia. The session will be moderated by co-founder and CEO of ReaGene Innovations Uday Saxena.

The discussion will focus on proposing solutions to promote innovation in biotech and pharma sectors, said a release from the organisers of BioAsia 2022, a two-day event being hosted by Government of Telangana and supported by FABA, from February 24.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.